康美药业 (600518)

Kangmei Pharmaceutical Co., Ltd.

ASH

Tags

AI HealthcareTraditional Chinese MedicineLow-Price StocksNew Insurance HoldingsPharmaceutical ManufacturingPharmaceuticals and HealthcareNon-GAAP LossesSmart HealthcarePrivate HospitalsGuangdong-Hong Kong-Macao Greater Bay AreaVitaminsMargin Trading and Securities LendingNon-Cyclical StocksHigh Price-to-Earnings Ratio

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 1382889.67
  • Circulating A-Shares(W): 1382235.22
  • Earnings Per Share(RMB): 0.0010
  • Net Assets Per Share(RMB): 0.5197
  • Operating Revenue(W RMB): 395960.35
  • Total Profit(W RMB): 3059.30
  • **Net Profit Attributable to Parent(W RMB) **: 1308.23
  • Net Profit Growth Rate(%): 160.84
  • Weighted Return on Equity(%): 0.1800
  • Operating Cash Flow Per Share(RMB): 0.0100
  • Undistributed Profit Per Share(RMB): -1.8714
  • Capital Reserve Per Share(RMB): 1.3359

2. Main Business

The main business covers:

  • Chinese herbal medicine trade
  • Production and sales of prepared slices of Chinese crude drugs, Chinese patent medicines, health foods, chemical drugs, and medical devices
  • Modern pharmaceutical logistics systems

3. Company Basic Information

  • Company Name: Kangmei Pharmaceutical Co., Ltd.
  • Listing Date: 2001-03-19
  • Industry: Pharmaceutical Manufacturing
  • Address: Tike Road, Xiameilin, Futian District, Shenzhen City, Guangdong Province
  • Website: http://www.kangmei.com.cn
  • Company Profile: The company was established on June 18, 1997, initiated by Puning Kangmei Industrial Co., Ltd., Puning International Information Consulting Service, Puning Jindian Pawnshop, and natural persons Xu Yanjun and Xu Dongjin, with a registered capital of 52.8 million yuan. Among them: Puning Kangmei Industrial Co., Ltd. subscribed for 41.2 million shares, accounting for 78% of the total share capital, using its evaluated assets of 23.092 million yuan in Guangdong Kangmei Pharmaceutical Co., Ltd. and 18.108 million yuan in cash at a 1:1 ratio. The other four initiators each subscribed for 2.9 million shares with 2.9 million yuan in cash at the same ratio, each accounting for 5.5% of the total share capital. The company's 18 million A-shares were issued online at a fixed price on February 26, 2001.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Guangdong Shennongshi Enterprise Management Partnership (Limited Partnership) Corporate Entity 350941.38 25.39
2 China Construction Bank Corporation Guangdong Provincial Branch Bank 51525.20 3.73
3 Kangmei Pharmaceutical Co., Ltd. Bankruptcy Estate Disposal Special Account Corporate Entity 18239.22 1.32
4 Shanghai Pudong Development Bank Co., Ltd. Shenzhen Branch Bank 10354.15 0.75
5 Tianjin Kunpeng Rongchuang Enterprise Management Consulting Co., Ltd. Corporate Entity 9816.75 0.71
6 Agricultural Bank of China Limited Shenzhen Branch Bank 9337.76 0.68
7 Bosera Fund - ICBC - Bosera - ICBC - Flexible Allocation No. 5 Specific Multiple Client Asset Management Plan Asset Management Plan 7941.69 0.57
8 Hong Kong Securities Clearing Company Ltd. Northbound Capital 7828.69 0.57
9 Zhongrong Life Insurance Co., Ltd. - Dividend Product Insurance 4680.64 0.34
10

5. Concept Sectors

  • Private Hospitals
  • Guangdong-Hong Kong-Macao Greater Bay Area
  • Vitamins
  • Intelligent Healthcare
  • AI Healthcare

Remarks

  • Data update date: 2025-10-30
  • Data source: Public market information